USP9YP17

associated omics data
USP9Y pseudogene 17Genealiases: []

Q-omics provides the consensus-scored USP9YP17 profile across patient tissues and cancer cell-line models. USP9YP17 expression is associated with patient survival in 1 of 34 cancer types, with the highest sampling consensus in LAML. Additionally, USP9YP17 RNA expression shows 24 significant gene co-expression associations, with the highest sampling consensus in LAML. Together, these results highlight LAML as cancer lineages where USP9YP17 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for USP9YP17 — synthetic lethality, tumor antigen, and pembrolizumab response.
View premium →

Survival associations

This table summarizes USP9YP17 survival associations across molecular data types. USP9YP17 RNA expression shows survival associations in the most cancer types (1). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
USP9YP17 data typeSurvival analysisLineage consensusLineage of highest sampling consensus
RNAKaplan–Meier1LAML (18)view →
This table ranks reproducible USP9YP17 RNA expression–survival associations across cancer types. High USP9YP17 expression shows unfavorable associations in LAML. The LAML Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p = .001). Together, the overview and detailed table identify LAML as the clearest survival context for USP9YP17 RNA expression.
LineageMeasureSplitStageAUC1
high
AUC2
low
pSampling consensus
LAMLDFSTertileAll0.0280.583.00118view →
Pink = unfavorable, green = favorable. all 1 lineages →

USP9YP17-LAML (DFS)

Kaplan–Meier survival curve for USP9YP17 RNA expression in LAML: high vs low expression groups.

Explore this curve interactively →

Cross-omics associations

This table shows molecular features associated with USP9YP17 in patient tissues and cancer cell lines. In patient samples, USP9YP17 shows the broadest associations at the RNA and protein expression levels, with LAML recurring as the lineage with the largest associated feature set.
Associated data typeStrength (# associated data)Lineage of highest associated data
▼RNA
RNA24LAML (24)view →